TF and neoplasm: In addition, Seidi et al. have used the GNGRAHA peptide for targeting molecules than other TF, e.g., staphylococcus coagulase in tumor vessels, and observed tumor accumulation and infarction in a PC3 human prostate tumor model with tolerability at therapeutic doses [110].